These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4993071)

  • 1. Transferrin saturation and erythropoietic activity in long-term hemodialyzed uremic patients.
    Gral T; Schroth P
    Am J Med Sci; 1970 Oct; 60(4):230-6. PubMed ID: 4993071
    [No Abstract]   [Full Text] [Related]  

  • 2. Disorders of red blood cell production in uremia.
    Eschbach JW; Adamson JW; Cook JD
    Arch Intern Med; 1970 Nov; 126(5):812-5. PubMed ID: 5475703
    [No Abstract]   [Full Text] [Related]  

  • 3. EFFECT OF HEMODIALYSIS ON ERYTHROKINETICS IN ANEMIA OF UREMIA.
    KURTIDES ES; RAMBACH WA; ALT HL; DELGRECO F
    J Lab Clin Med; 1964 Mar; 63():469-79. PubMed ID: 14164500
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanism and site of action of erythropoietic inhibiting factor in uremia.
    Moriyama Y
    Isr J Med Sci; 1971; 7(7):1012-5. PubMed ID: 5107152
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of total nephrectomy on hematopoiesis in patients undergoing chronic hemodialysis.
    Kominami N; Lowrie EG; Ianhez LE; Sakren A; Hampers CL; Merrill JP; Lange RD
    J Lab Clin Med; 1971 Oct; 78(4):524-32. PubMed ID: 5000358
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolysis and erythropoiesis. VI. A comparative study of the utilization of hemoglobin iron and transferrin iron by the erythropoietic tissue.
    Sanchez-Medal L; Duarte L; Labardini J
    Blood; 1970 May; 35(5):721-6. PubMed ID: 5446019
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of hypersiderosis. The long-term iron supplement in uremic patients treated with periodic dialysis].
    Lusvarghi E; Lamperi S
    Minerva Nefrol; 1982; 29(2):71-83. PubMed ID: 7133542
    [No Abstract]   [Full Text] [Related]  

  • 9. The kidney and erythropoiesis.
    Adamson JW; Eschbach J; Finch CA
    Am J Med; 1968 May; 44(5):725-33. PubMed ID: 4869104
    [No Abstract]   [Full Text] [Related]  

  • 10. [Iron balance in hemodialysis in chronic uremia].
    Kokot F; Warmuz A
    Z Urol Nephrol; 1988 Apr; 81(4):263-8. PubMed ID: 3400353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrarenal erythropoietin production.
    Fisher JW; Stuckey WJ; Lindholm DD; Abshire S
    Isr J Med Sci; 1971; 7(7):991-2. PubMed ID: 5098384
    [No Abstract]   [Full Text] [Related]  

  • 12. [PLASMA IRON TURNOVER AS AN INDEX OF ERYTHROPOIETIC ACTIVITY OF THE BONE MARROW].
    MEZA C; LITVAK J; FIGUEROA M; BETSALEL E
    Rev Med Chil; 1963 Dec; 91():894-7. PubMed ID: 14125683
    [No Abstract]   [Full Text] [Related]  

  • 13. The physiological significance of an erythropoietic inhibitor factor appearing in plasma subsequent to hypertransfusion.
    Whitcomb WH; Moore M
    Ann N Y Acad Sci; 1968 Mar; 149(1):462-71. PubMed ID: 5240737
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on erythropoiesis in patients with renal failure and after kidney transplantation.
    Ianhez LE; Maspes V; Sabbaga E
    Nephron; 1976; 17(6):439-48. PubMed ID: 796741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERYTHROPOIESIS IN ANEPHRIC MAN.
    NATHAN DG; SCHUPAK E; STOHLMAN F; MERRILL JP
    J Clin Invest; 1964 Nov; 43(11):2158-65. PubMed ID: 14223927
    [No Abstract]   [Full Text] [Related]  

  • 16. The soluble transferrin receptor: biological aspects and clinical usefulness as quantitative measure of erythropoiesis.
    Beguin Y
    Haematologica; 1992; 77(1):1-10. PubMed ID: 1398274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patients.
    Aljama P; Ward MK; Pierides AM; Eastham EJ; Ellis HA; Feest TG; Conceicao S; Kerr DN
    Clin Nephrol; 1978 Sep; 10(3):101-4. PubMed ID: 699405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum transferrin receptor concentration is not indicative of erythropoietic activity in chronic hemodialysis patients with poor response to recombinant human erythropoietin.
    Hou CC; Wu SC; Wu SC; Yang WC; Huang TP; Ng YY
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):456-62. PubMed ID: 9745161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte production and metabolism in anephric and uremic men.
    Nathan DG; Beck LH; Hampers CL; Merrill JP
    Ann N Y Acad Sci; 1968 Mar; 149(1):539-43. PubMed ID: 5240747
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on erythropoietic action of testosterone.
    Shirakura T; Azuma M; Maekawa T
    Acta Haematol; 1967; 38(1):49-56. PubMed ID: 4963350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.